31 research outputs found
Transcription factors expressed by T cell subtypes.
<p>Numbers of Th subtypes expressing the transcription factors T-bet (Th1; A), GATA-3 (Th2; B) RORγt (Th17; C) and FOXP3 (Treg; D) in the control (healthy non-asthmatics, n = 9), EOS high (asthmatics with elevated blood eosinophils, n = 11), and EOS low (asthmatics with low blood eosinophils, n = 12) groups. The horizontal line represents the median of the group. Filled symbols represent samples obtained in the winter time, while open symbols represent samples obtained during spring time.</p
Demographic and clinical characteristics of study participants.
¶<p>Non-reactive to methacholine up to a dose of 1.96 mg.</p>¶¶<p>One individual, not subjected to methacholine, was selected based on FEV<sub>1</sub> reversability with a value of 25%.</p>¶¶¶<p>Budesonide 400 µg/day at visit 2for all users, except one individual in EOS low group with a usage of 200 µg/day.</p>¶¶¶¶<p>Short acting β<sub>2</sub>-agonist is most frequently used.</p>¶¶¶¶¶<p>Budesonide 320 µg/day at visit 2 for all users.</p>†<p>Statistically significant in comparison with EOS low and healthy controls (***P<0.001).</p>††<p>Statistically significant in comparison with healthy controls (*P<0.05).</p
Alternative models for multiple transcription factor Th cells (Multi-TF).
<p>A) Multiple transcription factor cells are between naïve and terminally differentiated cells. B) Multiple transcription factor cells are differentiated cells that are transitioning from one cell type to another, going through a stage of multi expression before reaching the new type.</p
The distribution of T cell transcription factors differs in the lung microenvironments during allergic inflammation.
<p>A) Photographs of immunohistochemistry of MBP (red) in OVA or PBS exposed
sensitised mice, T-bet, GATA-3, Foxp3 (brown) and RORγt (red) in
peribronchial, perivascular and alveolar tissue after exposure to OVA in
sensitised mice. B) Quantification (cells/mm<sup>2</sup>) of T-bet,
GATA-3, Foxp3 and RORγt expressing cells in different compartments
of the lungs, including peribronchial tissue, perivascular tissue and
alveolar tissue, after exposure to PBS or OVA. Data shown as
mean+SEM, *<0.05. C) Pie chart showing the relative
distribution of T-bet, GATA-3, Foxp3 and RORγt expressing cells in
the different lung compartments after exposure of mice to OVA.</p
The expression of <i>in vitro</i> transcription factors.
<p>Values are expressed as percent of CD4<sup>+</sup> T cells.</p>*<p>P<0.05.</p>**<p>P<0.01.</p>***<p>P<0.001 in comparison to medium alone.</p><p>Stim. = stimulated. Medium = medium alone.</p><p>Bold lettering highlights the transcription factor of interest.</p
Fold change of gene expression in peribronchial, perivascular and alveolar lung tissue of OVA exposed mice compared to PBS control.
<p>Genes showed have fulfilled all quality criteria, including Ct value,
melting curve and melting temperature.</p><p>*RefSeq, reference sequence.</p
Proliferating CD4<sup>+</sup>CD25<sup>+</sup> cells expressing multiple transcription factors in fresh <i>ex vivo</i> whole blood from healthy non-asthmatic controls (n = 5).
<p>Antibody panel D: stained simultaneously with Ki-67/T-bet/GATA-3/RORγt. Antibody panel E: Ki-67/T-bet/RORγt/FOXP3. A) Percentage of Ki-67<sup>+</sup> (open bar) and Ki-67<b><sup>−</sup></b> (filled bar) CD4<sup>+</sup>CD25<sup>+</sup> cells. B) Percentage of CD4<sup>+</sup>CD25<sup>+</sup>Ki-67<sup>+</sup> expressing ≥ three transcription factors (open bar) or ≤three transcription factors (filled bar). C) Percentage of CD4<sup>+</sup>CD25<sup>+</sup>Ki-67<b><sup>−</sup></b> expressing ≥ three transcription factors (open bar) or ≤three transcription factors (filled bar). Data are expressed as mean±SEM.</p
Th cells increase after <i>in vitro</i> TCR stimulation.
<p>Three subsets of Th cells displayed fold change differences between the study groups: single expressing GATA-3<sup>+</sup>, co-expressingT-bet<sup>+</sup>GATA-3<sup>+</sup> and GATA-3<sup>+</sup>RORγt<sup>+</sup>FOXP3<sup>+</sup>, after 48 hours <i>in vitro</i> stimulation with anti-CD3/anti-CD28 antibodies. Data are expressed as mean±SEM. *p<0.05.</p
Gene expression in lung microenvironments during allergic inflammation.
<p>A) Fold change of genes related to allergic inflammation in
peribronchial, perivascular and alveolar tissue. Fold change is
calculated by comparing OVA exposed mice to PBS control. 3 fold change
threshold indicated by dotted line was considered biological relevant.
B) Network of differentially expressed genes in OVA exposed mice
compared to the PBS exposed controls. A network of genes associated with
allergic inflammation, generated by Ingenuity Pathways Analysis (3.0
fold change threshold), of OVA/OVA mice compared to OVA/PBS mice. The
expression of these genes in three lung microenvironments was examined;
peribronchial, perivascular and alveolar tissue. Lines indicate
relationships between molecules (solid
line = direct interaction; dashed
line = indirect interaction). Arrows at the end of
these lines indicate the direction of the interaction. Molecules that
are up-regulated and down-regulated in the dataset are coloured red and
green respectively. Darker colouring of the molecules indicates a higher
fold change. Grey molecules did not meet the threshold of 3 fold change.
Uncoloured molecules have been added from the Ingenuity Knowledge Base.
The exact fold change values of each molecule are shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0019889#pone-0019889-t001" target="_blank">Table 1</a>.</p
Sub analysis of circulating T-helper cell subtypes.
<p>Numbers of each subtype in the control (healthy non-asthmatics, n = 9), EOS high (asthmatics with elevated blood eosinophils, n = 11), and EOS low (asthmatics with low blood eosinophils, n = 12) groups. CD4<sup>+</sup>CD25<sup>+</sup> cells positive for only one of the transcription factors T-bet<sup>+</sup> (A), GATA-3<sup>+</sup> (B), RORγt<sup>+</sup> (C) and FOXP3<sup>+</sup> (D). CD4<sup>+</sup>CD25<sup>+</sup> cells co-expressing two transcription factors T-bet<sup>+</sup>GATA-3<sup>+</sup> (E), T-bet<sup>+</sup>RORγt<sup>+</sup> (F), T-bet<sup>+</sup>FOXP3<sup>+</sup> (G), GATA-3<sup>+</sup>RORγt<sup>+</sup> (H), GATA-3<sup>+</sup>FOXP3<sup>+</sup> (I) and RORγt<sup>+</sup>FOXP3<sup>+</sup> (J). CD4<sup>+</sup>CD25<sup>+</sup> cells positive for three transcription factors T-bet<sup>+</sup>GATA-3<sup>+</sup>RORγt<sup>+</sup> (K), T-bet<sup>+</sup>GATA-3<sup>+</sup>FOXP3<sup>+</sup> (L), T-bet<sup>+</sup>RORγt<sup>+</sup>FOXP3<sup>+</sup> (M) and GATA-3<sup>+</sup>RORγt<sup>+</sup>FOXP3<sup>+</sup> (N). CD4<sup>+</sup>CD25<sup>+</sup> cells expressing all four transcription factors T-bet<sup>+</sup>GATA-3<sup>+</sup>RORγt<sup>+</sup>FOXP3<sup>+</sup> (O). The horizontal line represents the median of the group. *p<0.05. Filled symbols represent samples obtained in the winter time, while open symbols represent samples obtained during spring time.</p